Anti-TGFβ Signaling Therapy: Balancing the Pros and Cons
Moderator: Rosemary J. Akhurst, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Speakers:
- Steven M. Albelda, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
- Neil A. Bhowmick, Vanderbilt University, Nashville, TN
Cancer Stem Cells: Somewhere, Everywhere, or Nowhere?
Moderator: Emmanuelle Passegué, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Speakers:
- Tessa L. Holyoake, University of Glasgow, Glasgow, United Kingdom
- Jeffrey M. Rosen, Baylor College of Medicine, Houston, TX
Cellular Senescence: Molecular Basis and Relevance for Cancer
Moderator: Jiri Bartek, Danish Cancer Society, Copenhagen, Denmark
Speakers:
- Fabrizio d’Adda di Fagagna, IFOM Foundation, Milano, Italy
- Pier Paolo Pandolfi, Beth Israel Deaconess Medical Center, Boston, MA
Oncology Drug Discovery in Academia: Key Strategies and Challenges
Moderator: Michael Morrissey, Exelixis, South San Francisco, CA
Speakers:
- James H. Doroshow, National Cancer Institute, Bethesda, MD
- Neil W. Gibson, Pfizer, Inc., La Jolla, CA
Integrating Immunology with Cancer Biology and Medicine
Moderator: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA
Speakers:
- Wolf Hervé Fridman, Unité INSERM 255, Paris, France
- Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY
The Role of Vitamin D in Cancer Prevention: What Do We Really Know?
Moderator: Virginia W. Hartmuller, The Scientific Consulting Group, Inc., Gaithersburg, MD
Speakers:
- Rachael Z. Stolzenberg-Solomon, National Cancer Institute, Rockville, MD
- Edward L. Giovannucci, Harvard School of Public Health, Boston, MA
- Joanne E. Manson, Brigham and Women’s Hospital, Boston, MA
|